1099499
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 8, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Cordova, TN (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 12401 | 21 CFR 1271.230(b) | Reduced risk representation |
| 12459 | 21 CFR 1271.320(b) | Sufficient information to draw conclusions |
| 12469 | 21 CFR 1271.350(a)(1) | Adverse reaction reporting to FDA |